🇺🇸 FDA
Patent

US 9572873

Method of inducing a T lymphocyte response using T-cell immunogens derived from anti-viral proteins

granted A61KA61K2039/555A61K2039/572

Quick answer

US patent 9572873 (Method of inducing a T lymphocyte response using T-cell immunogens derived from anti-viral proteins) held by The Regents of the University of California expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/555, A61K2039/572, A61K2039/58, A61K38/08